XML 9 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 20,450 $ 28,677
Short-term investments 51,074 51,732
Accounts receivable, net 65,322 60,137
Inventory 42,473 42,110
Prepaid expenses and other current assets 6,584 6,118
Total current assets 185,903 188,774
Property and equipment, net 19,306 20,166
Right-of-use lease assets 4,794 5,438
Other assets 7,884 8,128
Total assets 217,887 222,506
Current liabilities:    
Accounts payable 837 3,240
Accrued clinical and manufacturing liabilities 19,943 22,291
Accrued payroll and employee liabilities 7,647 9,224
Other accrued liabilities 43,814 41,855
Current lease liabilities 3,137 3,075
Total current liabilities 75,378 79,685
Non-current lease liabilities 2,045 2,800
Non-current notes payable, net 24,447 24,263
Non-current convertible notes payable, net 149,542 149,490
Other non-current liabilities 241 241
Total liabilities 251,653 256,479
Stockholders' deficit:    
Common stock 1,504 1,503
Additional paid-in capital 1,873,910 1,870,525
Accumulated other comprehensive (loss)/income (6) 13
Accumulated deficit (1,909,174) (1,906,014)
Total stockholders' deficit (33,766) (33,973)
Total liabilities and stockholders' deficit $ 217,887 $ 222,506